HEPATITIS C RETREATMENT OF A PATIENT WHO FAILED MULTIPLE TREATMENTS INCLUDING PROTEASE INHIBITOR AND NON-STRUCTURAL PROTEIN 5A INHIBITORS: A CASE REPORT
4CPS-255
CLINICAL EXPERIENCE OF CEFTAROLINE USE IN A THIRD LEVEL HOSPITAL
4CPS-254
A RETROSPECTIVE STUDY OF ANTIMICROBIAL STEWARDSHIP IN A UNIVERSITY HOSPITAL
4CPS-253
THE IMPORTANCE OF THE PHARMACOKINETIC PROFILE IN PATIENTS WITH ULTRA-RARE DISEASES:A CASE REPORT
4CPS-252
STUDY OF THE IMPLEMENTATION OF A VANCOMYCIN PHARMACOKINETIC MONITORING PROGRAMME IN PAEDIATRICS
4CPS-251
EVALUATION OF CLOSTRIDIUM DIFFICILE INFECTION MANAGEMENT PRIOR TO IMPLEMENTATION OF A PROTOCOL FOR IMPROVEMENT
4CPS-250
EVALUATION OF PRESCRIPTION ADEQUACY TO THE ANTIBIOTHERAPY PROTOCOL IN INTRA-ABDOMINAL INFECTION IN A REGIONAL HOSPITAL
4CPS-249
SECOND GENERATION β-LACTAM/ β-LACTAMASE INHIBITOR COMBINATIONS: CEFTAZIDIME-AVIBACTAM AND CEFTOLOZANE-TAZOBACTAM EXPERIENCE OF USE
4CPS-248
APPROPRIATENESS OF THE CLOSTRIDIUM DIFFICILE INFECTION PRESCRIPTION PRIOR TO THE IMPLEMENTATION OF A PROTOCOL FOR ITS MANAGEMENT
4CPS-247
VARIATIONS IN CONSUMPTION OF ANTIMICROBIALS IN INTERNAL MEDICINE WARDS OF HOSPITALS
4CPS-246
CORONAVIRUS FIRST WAVE EFFECT ON ANTIBIOTIC CONSUMPTION AND ANTIMICROBIAL RESISTANCE
4CPS-245
DURATION OF ANTIBIOTIC TREATMENT IN PATIENTS DISCHARGED FROM A SHORT STAY HOSPITALISATION UNIT
4CPS-244
THERAPEUTIC DRUG MONITORING GUIDED PHARMACY INTERVENTIONS TO OPTIMISE THE DOSAGE OF BETA-LACTAMS ADMINISTERED IN CONTINUOUS INFUSION IN NON-CRITICALLY ILL PATIENTS.
4CPS-243
HEALHCARE ASSOCIATED CLOSTRIDIOIDES DIFFICILE INFECTION IN SURGICAL AND MEDICAL PATIENTS
4CPS-242
ACUTE RESPIRATORY INFECTIONS: AN ANALYSIS OF HOSPITAL ANTIBIOTHERAPY PRESCRIPTION QUALITY FOR THE PAEDIATRIC POPULATION
